The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical technologies. This article examines the 2024 guidelines from the U.S. Patent and ...
Artificial Intelligence in Clinical Decision-Making: Regulatory Roadmap and Reimbursement Strategies
Artificial intelligence is rapidly transforming clinical medicine, with AI-powered tools increasingly being used for ...
SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of ...
SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) announces today that the Company will be sharing ...
As FDA medical device lawyers advising AI and digital health companies, Hogan Lovells lawyers have had a front-row seat to an increasingly common scenario: software platforms and mobile apps that ...
The FDA recalled 60 medical devices last year, and the running total for this year is 56. The good news is that there’s a startup working to make future totals lower. The startup, named Ketryx, ...
A Powerful SBOM Tool Purpose-Built for Medical Device Cybersecurity in a Complex Threat Landscape ICS’ ‘Software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback